The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy.
暂无分享,去创建一个
B. Hobbs | H. Carraway | A. Advani | M. Sekeres | A. Nazha | T. Radivoyevitch | B. Patel | S. Mukherjee | A. Gerds | A. Statler | C. Siebenaller